Results 31 to 40 of about 607 (121)

Examining the relationship between reproductive empowerment and contraceptive self-injection: Tackling the endogeneity problem. [PDF]

open access: yesPLoS ONE
BackgroundSelf-care interventions, including contraceptive self-injectables such as subcutaneous depot medroxyprogesterone acetate (DMPA-SC), are hypothesized to be empowering to users.
Megan M Lydon   +6 more
doaj   +2 more sources

Understanding clients’ and providers’ perspectives on the implementation of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) for self-injection programming in Nigeria [PDF]

open access: yesBMJ Global Health
Elizabeth Omoluabi   +9 more
doaj   +2 more sources

Self-injected contraceptives: does the investment reflect women’s preferences?

open access: yesBMJ Global Health, 2022
Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is an innovative contraceptive method aimed at meeting women’s unique circumstances and needs, largely due to its ability to be self-injected.
Sophia Magalona   +8 more
doaj   +1 more source

Testing a counseling message for increasing uptake of self-injectable contraception in southern Malawi: A mixed-methods, clustered randomized controlled study

open access: yesPLoS ONE, 2022
Objective While self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) has well-documented benefits, uptake may be improved by addressing client concerns such as fear of self-injury and low self-efficacy.
Holly M. Burke   +7 more
doaj   +2 more sources

Implementation strategies to scale up self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception: a scoping review

open access: yesSystematic Reviews, 2023
Background Self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception (DMPA-SC) is registered in many countries. It shows great potential for improving contraceptive access, continuation, and autonomy.
Adeniyi Kolade Aderoba   +2 more
doaj   +1 more source

“Men can take part”: examining men’s role in supporting self-injectable contraception in southern Malawi, a qualitative exploration

open access: yesReproductive Health, 2022
Plain language summary Self-injectable contraception (DMPA-SC) has the potential to expand family planning access. Once users are trained to self-inject, they can obtain multiple units and self-inject every three months privately, without needing to ...
Lucy W. Ruderman   +4 more
doaj   +1 more source

Missed opportunity for self-injectable contraception awareness and adoption: Insights from client exit interviews in Uganda and Nigeria

open access: yesContraception: X, 2023
Objectives: To assess the extent to which self-injection contraceptive information and services are provided to women in Uganda and Nigeria. Study design: We conducted a descriptive information cascade analysis using data from a cross-sectional exit ...
Susan Ontiri   +3 more
doaj   +1 more source

Client and provider experiences with self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Malawi [PDF]

open access: yesContraception, 2018
As low- and middle-income countries (LMICs) consider adding self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) to their contraceptive method mix, learning about family planning clients' and providers' experiences with self-injectable DMPA-SC during trials will inform introduction and scale-up efforts.We conducted ...
Holly M, Burke   +4 more
openaire   +2 more sources

Contraceptive self-injection through routine service delivery: Experiences of Ugandan women in the public health system

open access: yesFrontiers in Global Women's Health, 2022
Contraceptive self-injection (SI) is a new self-care practice with potential to transform women's family planning access by putting a popular method, injectable contraception, directly into the hands of users.
Jane Cover   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy